ID   LCLT1_HUMAN             Reviewed;         414 AA.
AC   Q6UWP7; A6H8Z7; Q8N1Q7;
DT   26-JUN-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   15-MAR-2017, entry version 114.
DE   RecName: Full=Lysocardiolipin acyltransferase 1;
DE            EC=2.3.1.-;
DE            EC=2.3.1.51;
DE   AltName: Full=1-acylglycerol-3-phosphate O-acyltransferase 8;
DE            Short=1-AGP acyltransferase 8;
DE            Short=1-AGPAT 8;
DE   AltName: Full=Acyl-CoA:lysocardiolipin acyltransferase 1;
GN   Name=LCLAT1; Synonyms=AGPAT8, ALCAT1, LYCAT; ORFNames=UNQ1849/PRO3579;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, TISSUE SPECIFICITY, AND MUTAGENESIS OF ASP-206.
RX   PubMed=16620771; DOI=10.1016/j.abb.2006.03.014;
RA   Agarwal A.K., Barnes R.I., Garg A.;
RT   "Functional characterization of human 1-acylglycerol-3-phosphate
RT   acyltransferase isoform 8: cloning, tissue distribution, gene
RT   structure, and enzymatic activity.";
RL   Arch. Biochem. Biophys. 449:64-76(2006).
RN   [6]
RP   FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF ASP-206 AND LEU-207.
RX   PubMed=19075029; DOI=10.1194/jlr.M800567-JLR200;
RA   Zhao Y., Chen Y.-Q., Li S., Konrad R.J., Cao G.;
RT   "The microsomal cardiolipin remodeling enzyme acyl-CoA lysocardiolipin
RT   acyltransferase is an acyltransferase of multiple anionic
RT   lysophospholipids.";
RL   J. Lipid Res. 50:945-956(2009).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-221, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
CC   -!- FUNCTION: Acyl-CoA:lysocardiolipin acyltransferase. Possesses both
CC       lysophosphatidylinositol acyltransferase (LPIAT) and
CC       lysophosphatidylglycerol acyltransferase (LPGAT) activities.
CC       Recognizes both monolysocardiolipin and dilysocardiolipin as
CC       substrates with a preference for linoleoyl-CoA and oleoyl-CoA as
CC       acyl donors. Acts as a remodeling enzyme for cardiolipin, a major
CC       membrane polyglycerophospholipid. Converts lysophosphatidic acid
CC       (LPA) into phosphatidic acid (PA) with a relatively low activity.
CC       Required for establishment of the hematopoietic and endothelial
CC       lineages. {ECO:0000269|PubMed:16620771,
CC       ECO:0000269|PubMed:19075029}.
CC   -!- CATALYTIC ACTIVITY: Acyl-CoA + 1-acyl-sn-glycerol 3-phosphate =
CC       CoA + 1,2-diacyl-sn-glycerol 3-phosphate.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=39 uM for arachidonoyl-CoA (20:4) for LPIAT activity
CC         {ECO:0000269|PubMed:19075029};
CC         KM=289 uM for oleoyl-CoA (18:1) for LPIAT activity
CC         {ECO:0000269|PubMed:19075029};
CC         KM=134 uM for linoleoyl-CoA (18:2) for LPIAT activity
CC         {ECO:0000269|PubMed:19075029};
CC         KM=34 uM for stearoyl-CoA (18:0) for LPIAT activity
CC         {ECO:0000269|PubMed:19075029};
CC         KM=53 uM for palmitoyl-CoA (16:0) for LPIAT activity
CC         {ECO:0000269|PubMed:19075029};
CC         KM=54 uM for oleoyl-CoA (18:1) for LPGAT activity
CC         {ECO:0000269|PubMed:19075029};
CC         KM=36 uM for linoleoyl-CoA (18:2) for LPGAT activity
CC         {ECO:0000269|PubMed:19075029};
CC         KM=70 uM for stearoyl-CoA (18:0) for LPGAT activity
CC         {ECO:0000269|PubMed:19075029};
CC         KM=34 uM for palmitoyl-CoA (16:0) for LPGAT activity
CC         {ECO:0000269|PubMed:19075029};
CC         Vmax=3230 nmol/min/mg enzyme toward arachidonoyl-CoA (20:4) for
CC         LPIAT activity {ECO:0000269|PubMed:19075029};
CC         Vmax=7489 nmol/min/mg enzyme toward oleoyl-CoA (18:1) for LPIAT
CC         activity {ECO:0000269|PubMed:19075029};
CC         Vmax=4696 nmol/min/mg enzyme toward linoleoyl-CoA (18:2) for
CC         LPIAT activity {ECO:0000269|PubMed:19075029};
CC         Vmax=1078 nmol/min/mg enzyme toward stearoyl-CoA (18:0) for
CC         LPIAT activity {ECO:0000269|PubMed:19075029};
CC         Vmax=11203 nmol/min/mg enzyme toward palmitoyl-CoA (16:0) for
CC         LPIAT activity {ECO:0000269|PubMed:19075029};
CC         Vmax=5514 nmol/min/mg enzyme toward oleoyl-CoA (18:1) for LPGAT
CC         activity {ECO:0000269|PubMed:19075029};
CC         Vmax=1358 nmol/min/mg enzyme toward linoleoyl-CoA (18:2) for
CC         LPGAT activity {ECO:0000269|PubMed:19075029};
CC         Vmax=3530 nmol/min/mg enzyme toward stearoyl-CoA (18:0) for
CC         LPGAT activity {ECO:0000269|PubMed:19075029};
CC         Vmax=1673 nmol/min/mg enzyme toward palmitoyl-CoA (16:0) for
CC         LPGAT activity {ECO:0000269|PubMed:19075029};
CC   -!- PATHWAY: Phospholipid metabolism; CDP-diacylglycerol biosynthesis;
CC       CDP-diacylglycerol from sn-glycerol 3-phosphate: step 2/3.
CC   -!- INTERACTION:
CC       Q9HD26:GOPC; NbExp=3; IntAct=EBI-10254507, EBI-349832;
CC       Q8TBB1:LNX1; NbExp=3; IntAct=EBI-10254507, EBI-739832;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:19075029}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:19075029}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6UWP7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6UWP7-2; Sequence=VSP_026181, VSP_026182;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q6UWP7-3; Sequence=VSP_044307;
CC   -!- TISSUE SPECIFICITY: Expressed at higher level in heart, kidney and
CC       pancreas than in brain, spleen, liver, lung, small intestine and
CC       placenta. {ECO:0000269|PubMed:16620771,
CC       ECO:0000269|PubMed:19075029}.
CC   -!- DOMAIN: The HXXXXD motif is essential for acyltransferase activity
CC       and may constitute the binding site for the phosphate moiety of
CC       the glycerol-3-phosphate. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the 1-acyl-sn-glycerol-3-phosphate
CC       acyltransferase family. {ECO:0000305}.
CC   -!- CAUTION: PubMed:16620771 does not detect acyl-CoA:lysocardiolipin
CC       acyltransferase activity. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY358702; AAQ89065.1; -; mRNA.
DR   EMBL; AK095284; BAC04522.1; -; mRNA.
DR   EMBL; AC073255; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC132154; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC146817; AAI46818.1; -; mRNA.
DR   CCDS; CCDS1772.1; -. [Q6UWP7-1]
DR   CCDS; CCDS42670.1; -. [Q6UWP7-3]
DR   RefSeq; NP_001002257.1; NM_001002257.2. [Q6UWP7-3]
DR   RefSeq; NP_001291374.1; NM_001304445.1. [Q6UWP7-3]
DR   RefSeq; NP_872357.2; NM_182551.4. [Q6UWP7-1]
DR   RefSeq; XP_005264301.1; XM_005264244.1. [Q6UWP7-1]
DR   RefSeq; XP_005264302.1; XM_005264245.3. [Q6UWP7-3]
DR   RefSeq; XP_011531043.1; XM_011532741.2. [Q6UWP7-1]
DR   RefSeq; XP_011531044.1; XM_011532742.2. [Q6UWP7-3]
DR   RefSeq; XP_011531045.1; XM_011532743.2. [Q6UWP7-3]
DR   RefSeq; XP_016859235.1; XM_017003746.1. [Q6UWP7-3]
DR   UniGene; Hs.468048; -.
DR   UniGene; Hs.662770; -.
DR   ProteinModelPortal; Q6UWP7; -.
DR   BioGrid; 128972; 27.
DR   IntAct; Q6UWP7; 4.
DR   STRING; 9606.ENSP00000310551; -.
DR   SwissLipids; SLP:000000126; -.
DR   iPTMnet; Q6UWP7; -.
DR   PhosphoSitePlus; Q6UWP7; -.
DR   BioMuta; LCLAT1; -.
DR   DMDM; 74749398; -.
DR   EPD; Q6UWP7; -.
DR   MaxQB; Q6UWP7; -.
DR   PaxDb; Q6UWP7; -.
DR   PeptideAtlas; Q6UWP7; -.
DR   PRIDE; Q6UWP7; -.
DR   TopDownProteomics; Q6UWP7-1; -. [Q6UWP7-1]
DR   Ensembl; ENST00000309052; ENSP00000310551; ENSG00000172954. [Q6UWP7-1]
DR   Ensembl; ENST00000319406; ENSP00000368826; ENSG00000172954. [Q6UWP7-2]
DR   Ensembl; ENST00000379509; ENSP00000368823; ENSG00000172954. [Q6UWP7-3]
DR   GeneID; 253558; -.
DR   KEGG; hsa:253558; -.
DR   UCSC; uc002rnj.3; human. [Q6UWP7-1]
DR   CTD; 253558; -.
DR   DisGeNET; 253558; -.
DR   GeneCards; LCLAT1; -.
DR   HGNC; HGNC:26756; LCLAT1.
DR   HPA; HPA031880; -.
DR   HPA; HPA049217; -.
DR   neXtProt; NX_Q6UWP7; -.
DR   OpenTargets; ENSG00000172954; -.
DR   PharmGKB; PA164722072; -.
DR   eggNOG; KOG1505; Eukaryota.
DR   eggNOG; COG0204; LUCA.
DR   GeneTree; ENSGT00530000062943; -.
DR   HOGENOM; HOG000290725; -.
DR   HOVERGEN; HBG055624; -.
DR   InParanoid; Q6UWP7; -.
DR   KO; K13513; -.
DR   OMA; PQSEKHL; -.
DR   OrthoDB; EOG091G0C4Z; -.
DR   PhylomeDB; Q6UWP7; -.
DR   TreeFam; TF314346; -.
DR   Reactome; R-HSA-1482798; Acyl chain remodeling of CL.
DR   Reactome; R-HSA-1483166; Synthesis of PA.
DR   Reactome; R-HSA-75109; Triglyceride Biosynthesis.
DR   UniPathway; UPA00557; UER00613.
DR   ChiTaRS; LCLAT1; human.
DR   GenomeRNAi; 253558; -.
DR   PRO; PR:Q6UWP7; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000172954; -.
DR   CleanEx; HS_LCLAT1; -.
DR   ExpressionAtlas; Q6UWP7; baseline and differential.
DR   Genevisible; Q6UWP7; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; TAS:Reactome.
DR   GO; GO:0008374; F:O-acyltransferase activity; TAS:Reactome.
DR   GO; GO:0035965; P:cardiolipin acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0016024; P:CDP-diacylglycerol biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome.
DR   InterPro; IPR032098; Acyltransf_C.
DR   InterPro; IPR002123; Plipid/glycerol_acylTrfase.
DR   Pfam; PF16076; Acyltransf_C; 1.
DR   Pfam; PF01553; Acyltransferase; 1.
DR   SMART; SM00563; PlsC; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Acyltransferase; Alternative splicing; Complete proteome;
KW   Developmental protein; Endoplasmic reticulum; Lipid biosynthesis;
KW   Lipid metabolism; Membrane; Phospholipid biosynthesis;
KW   Phospholipid metabolism; Polymorphism; Reference proteome;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    414       Lysocardiolipin acyltransferase 1.
FT                                /FTId=PRO_0000291577.
FT   TRANSMEM     47     67       Helical. {ECO:0000255}.
FT   TRANSMEM     86    106       Helical. {ECO:0000255}.
FT   TRANSMEM    340    360       Helical. {ECO:0000255}.
FT   TRANSMEM    362    382       Helical. {ECO:0000255}.
FT   MOTIF       123    128       HXXXXD motif.
FT   MOD_RES     221    221       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ       1     38       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_044307.
FT   VAR_SEQ     249    308       KNLDAVHDITVAYPHNIPQSEKHLLQGDFPREIHFHVHRYP
FT                                IDTLPTSKEDLQLWCHKRW -> RRQSEGSKGPLQGELQIT
FT                                AQGNQRGHKQMEKHSMLMDWKNQYREIGHTAQSNLQIQCYS
FT                                H (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_026181.
FT   VAR_SEQ     309    414       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_026182.
FT   VARIANT     290    290       I -> V (in dbSNP:rs12471868).
FT                                /FTId=VAR_032830.
FT   MUTAGEN     206    206       D->C: Abolishes LPIAT and LPGAT
FT                                activities. {ECO:0000269|PubMed:16620771,
FT                                ECO:0000269|PubMed:19075029}.
FT   MUTAGEN     206    206       D->R: Does not increase enzyme activity.
FT                                {ECO:0000269|PubMed:16620771,
FT                                ECO:0000269|PubMed:19075029}.
FT   MUTAGEN     207    207       L->T: Abolishes LPIAT activity. No effect
FT                                on LPGAT activity.
FT                                {ECO:0000269|PubMed:19075029}.
SQ   SEQUENCE   414 AA;  48920 MW;  F83A1911CC19F959 CRC64;
     MHSRGREIVV LLNPWSINEA VSSYCTYFIK QDSKSFGIMV SWKGIYFILT LFWGSFFGSI
     FMLSPFLPLM FVNPSWYRWI NNRLVATWLT LPVALLETMF GVKVIITGDA FVPGERSVII
     MNHRTRMDWM FLWNCLMRYS YLRLEKICLK ASLKGVPGFG WAMQAAAYIF IHRKWKDDKS
     HFEDMIDYFC DIHEPLQLLI FPEGTDLTEN SKSRSNAFAE KNGLQKYEYV LHPRTTGFTF
     VVDRLREGKN LDAVHDITVA YPHNIPQSEK HLLQGDFPRE IHFHVHRYPI DTLPTSKEDL
     QLWCHKRWEE KEERLRSFYQ GEKNFYFTGQ SVIPPCKSEL RVLVVKLLSI LYWTLFSPAM
     CLLIYLYSLV KWYFIITIVI FVLQERIFGG LEIIELACYR LLHKQPHLNS KKNE
//
